KEAP1 and lung cancer: FSP1 inhibition (using a FSP1 inhibitor iFSP1 or deleting FSP1 expression) largely promoted radiosensitization and IR-induced lipid peroxidation in KEAP1 deficient of mutant lung cancer cells [13], making FSP1 an ideal target for targeted treatment during radiotherapy.